Szafer‐Glusman, Edith
https://orcid.org/0000-0002-5720-881X
Mayo Clinic
Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA
Citations 1
PB1878: CROSS-TRIAL ANALYSIS OF FIXED-DURATION IBRUTINIB (I) PLUS VENETOCLAX (V) VS FLUDARABINE (F), CYCLOPHOSPHAMIDE (C), AND RITUXIMAB (R) AS FIRST-LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Mato, Anthony R. , Moreno, Carol , Szafer‐Glusman, Edith , Zhou, Cathy , Neumayr, Lynne , Krigsfeld, Gabriel , Barrientos, Jacqueline C. , Barr, Paul M. , Tam, Constantine S. , Ghia, Paolo , Kay, Neil E. , Siddiqi, Tanya , Wierda, William G. , Shanafelt, Tait D.
HemaSphere | June 24, 2022 | Volume: 6 | Issue: No issue available | Pages: 1758-1759
